| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC2279 |
| Trial ID | NCT04214392 |
| Disease | Glioblastoma |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CLTX-CAR-T cells |
| Generation | 2nd |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | Chimeric Antigen Receptor (CAR) T Cells With a Chlorotoxin Tumor-Targeting Domain for the Treatment of MMP2+ Recurrent or Progressive Glioblastoma |
| Year | 2020 |
| Country | United States |
| Company sponsor | City of Hope Medical Center |
| Other ID(s) | 19309|NCI-2019-08393|19309 |
| Cohort 1 | |||||||
|
|||||||